M-M-R II (Measles, Mumps, and Rubella Virus Vaccine Live) Drug Information: Medication Guide and Patient Information

Pill Identifier Search

May 27, 2012

M-M-R II

Mumps »

Mumps facts

Mumps is a highly contagious viral infection with an incubation period of 14-18 days from exposure to onset of symptoms. The duration of the disease is approximately 10 days.
The initial symptoms of mumps infection are nonspecific (low-grade fever, malaise, headache, muscle aches, and loss of appetite). The classic finding of parotid gland tenderness and swelling generally develops the third day of illness. The diagnosis is generally made without the need for laboratory tests.
Serious complications of mumps include meningitis, encephalitis, deafness, and orchitis.
The MMR vaccine provides 80% effective immunity against mumps following a two-dosage schedule (12-15 months with booster at 4-6 years of age).
No specific therapy exists for mumps. Warm or cold packs for the parotid gland tenderness and swelling is helpful. Pain relievers (acetaminophen [Tylenol] and ibuprofen [Advil]) are...

Read the Mumps article »

« Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
Next »

M-M-R II

Travel Health and Vaccines Slideshow Pictures

font size

PATIENT INFORMATION

The health-care provider should provide the vaccine information required to be given with each vaccination to the patient, parent, or guardian.

The health-care provider should inform the patient, parent, or guardian of the benefits and risks associated with vaccination. For risks associated with vaccination see WARNINGS, PRECAUTIONS, ADVERSE REACTIONS.

Patients, parents, or guardians should be instructed to report any serious adverse reactions to their health-care provider who in turn should report such events to the U.S. Department of Health and Human Services through the Vaccine Adverse Event Reporting System (VAERS), 1-800-822-7967.⁴⁷

Pregnancy should be avoided for 3 months following vaccination, and patients should be informed of the reasons for this precaution (see INDICATIONS AND USAGE, Non-Pregnant Adolescent and Adult Females, CONTRAINDICATIONS, and PRECAUTIONS, Pregnancy).

REFERENCES

47. Vaccine Adverse Event Reporting System — United States, MMWR 39(41): 730-733, October 19, 1990.

Last reviewed on RxList: 11/21/2008
This monograph has been modified to include the generic and brand name in many instances.